Hypertension — Stanford Five-City Multifactor Risk Reduction Study
Citation(s)
Albright CL, Flora JA, Fortmann SP Restaurant menu labeling: impact of nutrition information on entree sales and patron attitudes. Health Educ Q. 1990 Summer;17(2):157-67.
Davis SK, Ahn DK, Fortmann SP, Farquhar JW Determinants of cholesterol screening and treatment patterns. Insights for decision-makers. Am J Prev Med. 1998 Oct;15(3):178-86. Erratum in: Am J Prev Med 1998 Nov;15(4):433.
Davis SK, Winkleby MA, Farquhar JW Increasing disparity in knowledge of cardiovascular disease risk factors and risk-reduction strategies by socioeconomic status: implications for policymakers. Am J Prev Med. 1995 Sep-Oct;11(5):318-23.
Fortmann SP, Haskell WL, Williams PT Changes in plasma high density lipoprotein cholesterol after changes in cigarette use. Am J Epidemiol. 1986 Oct;124(4):706-10.
Fortmann SP, Sallis JF, Magnus PM, Farquhar JW Attitudes and practices of physicians regarding hypertension and smoking: The Stanford Five City Project. Prev Med. 1985 Jan;14(1):70-80.
Fortmann SP, Taylor CB, Flora JA, Jatulis DE Changes in adult cigarette smoking prevalence after 5 years of community health education: the Stanford Five-City Project. Am J Epidemiol. 1993 Jan 1;137(1):82-96.
Fortmann SP, Taylor CB, Flora JA, Winkleby MA Effect of community health education on plasma cholesterol levels and diet: the Stanford Five-City Project. Am J Epidemiol. 1993 May 15;137(10):1039-55.
Fortmann SP, Varady AN Effects of a community-wide health education program on cardiovascular disease morbidity and mortality: the Stanford Five-City Project. Am J Epidemiol. 2000 Aug 15;152(4):316-23.
Gardner CD, Fortmann SP, Krauss RM Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996 Sep 18;276(11):875-81.
Gardner CD, Tribble DL, Young DR, Ahn D, Fortmann SP Associations of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B with lifestyle factors in healthy women and men: the Stanford Five City Project. Prev Med. 2000 Oct;31(4):346-56.
Gardner CD, Tribble DL, Young DR, Ahn D, Fortmann SP Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project. Prev Med. 2000 Oct;31(4):335-45.
Greeno CG, Jackson C, Williams EL, Fortmann SP The effect of perceived control over eating on the life satisfaction of women and men: results from a community sample. Int J Eat Disord. 1998 Dec;24(4):415-9.
Jackson C, Jatulis DE, Fortmann SP The Behavioral Risk Factor Survey and the Stanford Five-City Project Survey: a comparison of cardiovascular risk behavior estimates. Am J Public Health. 1992 Mar;82(3):412-6.
Jackson C, Winkleby MA, Flora JA, Fortmann SP Use of educational resources for cardiovascular risk reduction in the Stanford Five-City Project. Am J Prev Med. 1991 Mar-Apr;7(2):82-8.
King AC, Flora JA, Fortmann SP, Taylor CB Smokers' challenge: immediate and long-term findings of a community smoking cessation contest. Am J Public Health. 1987 Oct;77(10):1340-1.
King AC, Kiernan M, Ahn DK, Wilcox S The effects of marital transitions on changes in physical activity: results from a 10-year community study. Ann Behav Med. 1998 Spring;20(2):64-9.
Maron DJ, Fortmann SP Nicotine yield and measures of cigarette smoke exposure in a large population: are lower-yield cigarettes safer? Am J Public Health. 1987 May;77(5):546-9.
Oka RK, Fortmann SP, Varady AN Differences in treatment of acute myocardial infarction by sex, age, and other factors (the Stanford Five-City Project). Am J Cardiol. 1996 Oct 15;78(8):861-5.
Ribisl KM, Winkleby MA, Fortmann SP, Flora JA The interplay of socioeconomic status and ethnicity on Hispanic and white men's cardiovascular disease risk and health communication patterns. Health Educ Res. 1998 Sep;13(3):407-17.
Rimal RN Closing the knowledge-behavior gap in health promotion: the mediating role of self-efficacy. Health Commun. 2000;12(3):219-37.
Tuomilehto J, Kuulasmaa K, Torppa J WHO MONICA Project: geographic variation in mortality from cardiovascular diseases. Baseline data on selected population characteristics and cardiovascular mortality. World Health Stat Q. 1987;40(2):171-84. English, French.
Wild SH, Fortmann SP, Marcovina SM A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vasc Biol. 1997 Feb;17(2):239-45. Erratum in: Arterioscler Throm Vasc Biol 1997 May;17(5):1010.
Williams EL, Winkleby MA, Fortmann SP Changes in coronary heart disease risk factors in the 1980s: evidence of a male-female crossover effect with age. Am J Epidemiol. 1993 May 15;137(10):1056-67.
Williams JE, Flora JA Health behavior segmentation and campaign planning to reduce cardiovascular disease risk among Hispanics. Health Educ Q. 1995 Feb;22(1):36-48.
Williams PT, Karlin S, Farquhar JW Permutation analyses of familial association arrays for lipoprotein concentrations in families of the Stanford Five City Project. Am J Epidemiol. 1987 Dec;126(6):1126-40.
Winkleby MA, Feldman HA, Murray DM Joint analysis of three U.S. community intervention trials for reduction of cardiovascular disease risk. J Clin Epidemiol. 1997 Jun;50(6):645-58.
Winkleby MA, Fortmann SP, Barrett DC Social class disparities in risk factors for disease: eight-year prevalence patterns by level of education. Prev Med. 1990 Jan;19(1):1-12.
Winkleby MA, Fortmann SP, Rockhill B Health-related risk factors in a sample of Hispanics and whites matched on sociodemographic characteristics. The Stanford Five-City Project. Am J Epidemiol. 1993 Jun 15;137(12):1365-75.
Winkleby MA, Fortmann SP, Rockhill B Trends in cardiovascular disease risk factors by educational level: the Stanford Five-City Project. Prev Med. 1992 Sep;21(5):592-601.
Winkleby MA, Gardner CD, Taylor CB The influence of gender and socioeconomic factors on Hispanic/white differences in body mass index. Prev Med. 1996 Mar-Apr;25(2):203-11.
Winkleby MA, Jatulis DE, Frank E, Fortmann SP Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992 Jun;82(6):816-20.
Winkleby MA, Taylor CB, Jatulis D, Fortmann SP The long-term effects of a cardiovascular disease prevention trial: the Stanford Five-City Project. Am J Public Health. 1996 Dec;86(12):1773-9.
Young DR, Haskell WL, Jatulis DE, Fortmann SP Associations between changes in physical activity and risk factors for coronary heart disease in a community-based sample of men and women: the Stanford Five-City Project. Am J Epidemiol. 1993 Aug 15;138(4):205-16.
Young DR, Haskell WL, Taylor CB, Fortmann SP Effect of community health education on physical activity knowledge, attitudes, and behavior. The Stanford Five-City Project. Am J Epidemiol. 1996 Aug 1;144(3):264-74.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.